Literature DB >> 17114474

The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I.

Patrick Paladino1, Derek T Cummings, Ryan S Noyce, Karen L Mossman.   

Abstract

The innate immune system responds to pathogen infection by eliciting a nonspecific immune response following the recognition of various pathogen-associated molecular patterns. TLRs and the RNA helicases retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 recognize foreign nucleic acid within endosomal and cytoplasmic compartments, respectively, initiating a signaling cascade that involves the induction of type I IFN through the transcription factors IFN regulatory factor (IRF) 3 and NF-kappaB. However, a recent paradigm has emerged in which bacterial DNA and double-stranded B-form DNA trigger type I IFN production through an uncharacterized TLR- and RIG-I-independent pathway. We have previously described a response in primary fibroblasts wherein the entry of diverse RNA- and DNA-enveloped virus particles is sufficient to induce a subset of IFN-stimulated genes and a complete antiviral response in an IRF3-dependent, IFN-independent manner. In this study, we show that the innate immune response to virus particle entry is independent of both TLR and RIG-I pathways, confirming the existence of novel innate immune mechanisms that result in the activation of IRF3. Furthermore, we propose a model of innate antiviral immunity in which exposure to increasing numbers of virus particles elevates the complexity of the cellular response from an intracellular, IFN-independent response to one involving secretion of cytokines and activation of infiltrating immune cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114474     DOI: 10.4049/jimmunol.177.11.8008

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

2.  Cell fusion-induced activation of interferon-stimulated genes is not required for restriction of a herpes simplex virus VP16/ICP0 mutant in heterokarya formed between permissive and restrictive cells.

Authors:  Meaghan H Hancock; Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

3.  A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA.

Authors:  Myoung Kwon Choi; ZhiChao Wang; Tatsuma Ban; Hideyuki Yanai; Yan Lu; Ryuji Koshiba; Yukana Nakaima; Sho Hangai; David Savitsky; Makoto Nakasato; Hideo Negishi; Osamu Takeuchi; Kenya Honda; Shizuo Akira; Tomohiko Tamura; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-01       Impact factor: 11.205

4.  Membrane perturbation elicits an IRF3-dependent, interferon-independent antiviral response.

Authors:  Ryan S Noyce; Kathryne Taylor; Marta Ciechonska; Susan E Collins; Roy Duncan; Karen L Mossman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 5.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

6.  Herpes simplex virus type 1 induces simultaneous activation of Toll-like receptors 2 and 4 and expression of the endogenous ligand serum amyloid A in astrocytes.

Authors:  Melina Villalba; Melissa Hott; Carolina Martin; Blanca Aguila; Sharin Valdivia; Claudia Quezada; Angara Zambrano; Margarita I Concha; Carola Otth
Journal:  Med Microbiol Immunol       Date:  2012-05-24       Impact factor: 3.402

7.  Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling.

Authors:  Daniel C Peltier; Allison Simms; Jocelyn R Farmer; David J Miller
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

8.  Differential modification of interferon regulatory factor 3 following virus particle entry.

Authors:  Ryan S Noyce; Susan E Collins; Karen L Mossman
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses.

Authors:  Patrick Paladino; Susan E Collins; Karen L Mossman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Unraveling the complexities of the interferon response during SARS-CoV infection.

Authors:  Anna de Lang; Tracey Baas; Saskia L Smits; Michael G Katze; Albert Dme Osterhaus; Bart L Haagmans
Journal:  Future Virol       Date:  2009-01-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.